{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:00:23Z","timestamp":1768698023273,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Understanding the effects of metabolism on the rational design of novel and more effective drugs is still a considerable challenge. To the best of our knowledge, there are no entirely computational strategies that make it possible to predict these effects. From this perspective, the development of such methodologies could contribute to significantly reduce the side effects of medicines, leading to the emergence of more effective and safer drugs. Thereby, in this study, our strategy is based on simulating the electron ionization mass spectrometry (EI-MS) fragmentation of the drug molecules and combined with molecular docking and ADMET models in two different situations. In the first model, the drug is docked without considering the possible metabolic effects. In the second model, each of the intermediates from the EI-MS results is docked, and metabolism occurs before the drug accesses the biological target. As a proof of concept, in this work, we investigate the main antiviral drugs used in clinical research to treat COVID-19. As a result, our strategy made it possible to assess the biological activity and toxicity of all potential by-products. We believed that our findings provide new chemical insights that can benefit the rational development of novel drugs in the future.<\/jats:p>","DOI":"10.1038\/s41598-021-99451-1","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T10:25:59Z","timestamp":1633602359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effect of drug metabolism in the treatment of SARS-CoV-2 from an entirely computational perspective"],"prefix":"10.1038","volume":"11","author":[{"given":"Jo\u00e3o Paulo Almir\u00e3o","family":"de Jesus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Let\u00edcia Cristina","family":"Assis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Alves","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine Fontes Ferreira","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenie","family":"Nepovimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodorico","family":"de Castro Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"de Almeida La Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"key":"99451_CR1","volume-title":"WHO Coronavirus Disease (COVID-19) Dashboard","author":"WHO","year":"2021","unstructured":"WHO. WHO Coronavirus Disease (COVID-19) Dashboard (World Health Organization, 2021)."},{"key":"99451_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271-280.e8 (2020).","journal-title":"Cell"},{"key":"99451_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","volume":"115","author":"YM B\u00e1ez-Santos","year":"2015","unstructured":"B\u00e1ez-Santos, Y. M., St. John, S. E. & Mesecar, A. D. The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds. Antiviral Res. 115, 21\u201338 (2015).","journal-title":"Antiviral Res."},{"key":"99451_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/cbic.202000047","volume":"21","author":"JS Morse","year":"2020","unstructured":"Morse, J. S., Lalonde, T., Xu, S. & Liu, W. R. Learning from the Past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. ChemBioChem 21, 730\u2013738 (2020).","journal-title":"ChemBioChem"},{"key":"99451_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"J Shang","year":"2020","unstructured":"Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221\u2013224 (2020).","journal-title":"Nature"},{"key":"99451_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","volume":"581","author":"J Lan","year":"2020","unstructured":"Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215\u2013220 (2020).","journal-title":"Nature"},{"key":"99451_CR7","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41401-020-0438-y","volume":"41","author":"H Li","year":"2020","unstructured":"Li, H. et al. Overview of therapeutic drug research for COVID-19 in China. Acta Pharmacol. Sin. 41, 1133\u20131140 (2020).","journal-title":"Acta Pharmacol. Sin."},{"key":"99451_CR8","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3666250","author":"T Bobrowski","year":"2020","unstructured":"Bobrowski, T. et al. Discovery of synergistic and antagonistic drug combinations against SARS-CoV-2 in vitro. SSRN Electron. J. https:\/\/doi.org\/10.2139\/ssrn.3666250 (2020).","journal-title":"SSRN Electron. J."},{"key":"99451_CR9","doi-asserted-by":"publisher","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","volume":"253","author":"AA Elfiky","year":"2020","unstructured":"Elfiky, A. A. Ribavirin, remdesivir, sofosbuvir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sci. 253, 117592 (2020).","journal-title":"Life Sci."},{"key":"99451_CR10","doi-asserted-by":"publisher","first-page":"e22379","DOI":"10.1097\/MD.0000000000022379","volume":"99","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Li, W., Jiang, Z., Xi, X. & Zhu, Y. Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19). Medicine 99, e22379 (2020).","journal-title":"Medicine"},{"key":"99451_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res."},{"key":"99451_CR12","doi-asserted-by":"crossref","unstructured":"Assis, L. C., de Castro, A. A., de Jesus, J. P. A., de Ramalho, T. C. & de A. La Porta, F. Theoretical insights into the effect of halogenated substituent on the electronic structure and spectroscopic properties of the favipiravir tautomeric forms and its implications on the treatment of COVID-19. ChemRxiv (2020).","DOI":"10.26434\/chemrxiv.12977597.v1"},{"key":"99451_CR13","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-66640\/v1","author":"A de Castro","year":"2020","unstructured":"de Castro, A., Assis, L., Ramalho, T. & Porta, F. L. New in silico insights into the application of the (hydroxy)chloroquine with macrolide antibiotics co-crystals against the SARS-CoV-2 virus. Medicine https:\/\/doi.org\/10.21203\/rs.3.rs-66640\/v1 (2020).","journal-title":"Medicine"},{"key":"99451_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/03602532.2014.882353","volume":"46","author":"B D\u00f6ring","year":"2014","unstructured":"D\u00f6ring, B. & Petzinger, E. Phase 0 and phase III transport in various organs: Combined concept of phases in xenobiotic transport and metabolism. Drug Metab. Rev. 46, 261\u2013282 (2014).","journal-title":"Drug Metab. Rev."},{"key":"99451_CR15","volume-title":"Detoxification Mechanisms: The Metabolism and Detoxification of Drugs, Toxic Substances and Other Organic Compounds","author":"RT Williams","year":"1959","unstructured":"Williams, R. T. Detoxification Mechanisms: The Metabolism and Detoxification of Drugs, Toxic Substances and Other Organic Compounds (Chapman and Hall, 1959)."},{"key":"99451_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-7050-4_1","author":"JR Gillette","year":"1963","unstructured":"Gillette, J. R. Metabolism of drugs and other foreign compounds by enzymatic mechanisms. Progress Drug Res. https:\/\/doi.org\/10.1007\/978-3-0348-7050-4_1 (1963).","journal-title":"Progress Drug Res."},{"key":"99451_CR17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0968-0004(92)90489-V","volume":"17","author":"T Ishikawa","year":"1992","unstructured":"Ishikawa, T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 17, 463\u2013468 (1992).","journal-title":"Trends Biochem. Sci."},{"key":"99451_CR18","unstructured":"Frisch, M. J. et al. Gaussian, Inc. (2009)."},{"key":"99451_CR19","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1002\/anie.201300158","volume":"52","author":"S Grimme","year":"2013","unstructured":"Grimme, S. Towards first principles calculation of electron impact mass spectra of molecules. Angew. Chem. Int. Ed. 52, 6306\u20136312 (2013).","journal-title":"Angew. Chem. Int. Ed."},{"key":"99451_CR20","doi-asserted-by":"publisher","first-page":"15120","DOI":"10.1021\/acsomega.9b02011","volume":"4","author":"J Koopman","year":"2019","unstructured":"Koopman, J. & Grimme, S. Calculation of electron ionization mass spectra with semiempirical GFNn-xTB methods. ACS Omega 4, 15120\u201315133 (2019).","journal-title":"ACS Omega"},{"key":"99451_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell, M. D. et al. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4, 17 (2012).","journal-title":"J. Cheminform."},{"key":"99451_CR22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"99451_CR23","doi-asserted-by":"publisher","first-page":"6628","DOI":"10.1021\/acsomega.9b04403","volume":"5","author":"EHB Maia","year":"2020","unstructured":"Maia, E. H. B., Medaglia, L. R., da Silva, A. M. & Taranto, A. G. Molecular architect: A user-friendly workflow for virtual screening. ACS Omega 5, 6628\u20136640 (2020).","journal-title":"ACS Omega"},{"key":"99451_CR24","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-32468\/v1","author":"LC Assis","year":"2020","unstructured":"Assis, L. C. et al. Nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection. ACS Omega https:\/\/doi.org\/10.21203\/rs.3.rs-32468\/v1 (2020).","journal-title":"ACS Omega"},{"key":"99451_CR25","doi-asserted-by":"publisher","first-page":"6397","DOI":"10.1038\/s41598-021-85280-9","volume":"11","author":"LC Assis","year":"2021","unstructured":"Assis, L. C. et al. Computational evidence for nitro derivatives of quinoline and quinoline N-oxide as low-cost alternative for the treatment of SARS-CoV-2 infection. Sci. Rep. 11, 6397 (2021).","journal-title":"Sci. Rep."},{"key":"99451_CR26","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1021\/jp984217f","volume":"103","author":"WRP Scott","year":"1999","unstructured":"Scott, W. R. P. et al. The GROMOS biomolecular simulation program package. J. Phys. Chem. A 103, 3596\u20133607 (1999).","journal-title":"J. Phys. Chem. A"},{"key":"99451_CR27","first-page":"493","volume":"8","author":"G Deepa","year":"2018","unstructured":"Deepa, G., Sivakumar, K. C. & Sajeevan, T. P. Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours. Biotech 8, 493 (2018).","journal-title":"Biotech"},{"key":"99451_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. V. M. D. Visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"99451_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2165\/00003088-199631040-00003","volume":"31","author":"J Ducharme","year":"1996","unstructured":"Ducharme, J. & Farinotti, R. Clinical pharmacokinetics and metabolism of chloroquine. Clin. Pharmacokinet. 31, 257\u2013274 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"99451_CR30","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/j.1552-4604.1989.tb03362.x","volume":"29","author":"EI Ette","year":"1989","unstructured":"Ette, E. I., Essien, E. E., Thomas, W. O. A. & Brown-Awala, E. A. Pharmacokinetics of chloroquine and some of its metabolites in healthy volunteers: A single dose study. J. Clin. Pharmacol. 29, 457\u2013462 (1989).","journal-title":"J. Clin. Pharmacol."},{"key":"99451_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0041-008X(65)90050-5","volume":"7","author":"EW McChesney","year":"1965","unstructured":"McChesney, E. W., Banks, W. F. & Sullivan, D. J. Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats. Toxicol. Appl. Pharmacol. 7, 627\u2013636 (1965).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"99451_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cotox.2018.07.001","volume":"9","author":"H Reingruber","year":"2018","unstructured":"Reingruber, H. & Pontel, L. B. Formaldehyde metabolism and its impact on human health. Curr. Opin. Toxicol. 9, 28\u201334 (2018).","journal-title":"Curr. Opin. Toxicol."},{"key":"99451_CR33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1001\/jama.1981.03320110049029","volume":"246","author":"JT Eells","year":"1981","unstructured":"Eells, J. T. Formaldehyde poisoning. JAMA 246, 1237 (1981).","journal-title":"JAMA"},{"key":"99451_CR34","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1073\/pnas.1103352108","volume":"108","author":"JM Roberts","year":"2011","unstructured":"Roberts, J. M. et al. Isocyanic acid in the atmosphere and its possible link to smoke-related health effects. Proc. Natl. Acad. Sci. 108, 8966\u20138971 (2011).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"99451_CR35","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm1637","volume":"13","author":"Z Wang","year":"2007","unstructured":"Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat. Med. 13, 1176\u20131184 (2007).","journal-title":"Nat. Med."},{"key":"99451_CR36","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3109\/15563658108990043","volume":"18","author":"SN Vogel","year":"1981","unstructured":"Vogel, S. N., Sultan, T. R. & Ten Eyck, R. P. Cyanide poisoning. Clin. Toxicol. 18, 367\u2013383 (1981).","journal-title":"Clin. Toxicol."},{"key":"99451_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S0140-6736(80)91121-6","volume":"315","author":"WJ Jenkins","year":"1980","unstructured":"Jenkins, W. J. & Peters, T. J. selectively reduced hepatic acetaldehyde dehydrogenase in alcoholics. Lancet 315, 628\u2013629 (1980).","journal-title":"Lancet"},{"key":"99451_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/mnfr.200700412","volume":"52","author":"JF Stevens","year":"2008","unstructured":"Stevens, J. F. & Maier, C. S. Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol. Nutr. Food Res. 52, 7\u201325 (2008).","journal-title":"Mol. Nutr. Food Res."},{"key":"99451_CR39","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1002\/(SICI)1521-3765(19981204)4:12<2550::AID-CHEM2550>3.0.CO;2-E","volume":"4","author":"D Schr\u00f6der","year":"1998","unstructured":"Schr\u00f6der, D. et al. Ethylenedione: An intrinsically short-lived molecule. Chem. A Eur. J. 4, 2550\u20132557 (1998).","journal-title":"Chem. A Eur. J."},{"key":"99451_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00039896.1978.10667314","volume":"33","author":"EL Baker","year":"1978","unstructured":"Baker, E. L. et al. Phenol poisoning due to contaminated drinking water. Arch. Environ. Health An Int. J. 33, 89\u201394 (1978).","journal-title":"Arch. Environ. Health An Int. J."},{"key":"99451_CR41","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/cbdv.200790059","volume":"4","author":"R Saladino","year":"2007","unstructured":"Saladino, R., Crestini, C., Ciciriello, F., Costanzo, G. & Di Mauro, E. Formamide chemistry and the origin of informational polymers. Chem. Biodivers. 4, 694\u2013720 (2007).","journal-title":"Chem. Biodivers."},{"key":"99451_CR42","doi-asserted-by":"publisher","first-page":"16729","DOI":"10.1074\/jbc.M611346200","volume":"282","author":"G Costanzo","year":"2007","unstructured":"Costanzo, G., Saladino, R., Crestini, C., Ciciriello, F. & Di Mauro, E. Nucleoside phosphorylation by phosphate minerals. J. Biol. Chem. 282, 16729\u201316735 (2007).","journal-title":"J. Biol. Chem."},{"key":"99451_CR43","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.plrev.2011.12.002","volume":"9","author":"R Saladino","year":"2012","unstructured":"Saladino, R., Crestini, C., Pino, S., Costanzo, G. & Di Mauro, E. Formamide and the origin of life. Phys. Life Rev. 9, 84\u2013104 (2012).","journal-title":"Phys. Life Rev."},{"key":"99451_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1177\/0748233713480205","volume":"31","author":"J-F Huang","year":"2015","unstructured":"Huang, J.-F., Zhu, D.-M., Ma, J.-F. & Zhong, M. Acute respiratory distress syndrome due to exposure to high-concentration mixture of ethenone and crotonaldehyde. Toxicol. Ind. Health 31, 585\u2013587 (2015).","journal-title":"Toxicol. Ind. Health"},{"key":"99451_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jmb.2009.04.069","volume":"390","author":"DF Zamyatkin","year":"2009","unstructured":"Zamyatkin, D. F., Parra, F., Mach\u00edn, A., Grochulski, P. & Ng, K.K.-S. Binding of 2\u2019-amino-2\u2019-deoxycytidine-5\u2019-triphosphate to norovirus polymerase induces rearrangement of the active site. J. Mol. Biol. 390, 10\u201316 (2009).","journal-title":"J. Mol. Biol."},{"key":"99451_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"99451_CR47","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/med.1016","volume":"21","author":"GN Kumar","year":"2001","unstructured":"Kumar, G. N. & Surapaneni, S. Role of drug metabolism in drug discovery and development. Med. Res. Rev. 21, 397\u2013411 (2001).","journal-title":"Med. Res. Rev."},{"key":"99451_CR48","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/rcm.8235","volume":"33","author":"F Cuyckens","year":"2019","unstructured":"Cuyckens, F. Mass spectrometry in drug metabolism and pharmacokinetics: Current trends and future perspectives. Rapid Commun. Mass Spectrom. 33, 90\u201395 (2019).","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"99451_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ph11020057","volume":"11","author":"JK Yella","year":"2018","unstructured":"Yella, J. K., Yaddanapudi, S., Wang, Y. & Jegga, A. G. Changing trends in computational drug repositioning. Pharmaceuticals 11, 1\u201310 (2018).","journal-title":"Pharmaceuticals"},{"key":"99451_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-60761-839-3_9","volume":"672","author":"A Varnek","year":"2011","unstructured":"Varnek, A. Fragment descriptors in structure-property modeling and virtual screening. Methods Mol. Biol. 672, 213\u2013243 (2011).","journal-title":"Methods Mol. Biol."},{"key":"99451_CR51","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fchem.2020.00343","volume":"8","author":"EHB Maia","year":"2020","unstructured":"Maia, E. H. B., Assis, L. C., de Oliveira, T. A., da Silva, A. M. & Taranto, A. G. Structure-based virtual screening: from classical to artificial intelligence. Front. Chem. 8, 43 (2020).","journal-title":"Front. Chem."},{"key":"99451_CR52","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1016\/j.ddtec.2013.02.002","volume":"10","author":"MN Drwal","year":"2013","unstructured":"Drwal, M. N. & Griffith, R. Combination of ligand- and structure-based methods in virtual screening. Drug Discov. Today Technol. 10, e395\u2013e401 (2013).","journal-title":"Drug Discov. Today Technol."},{"key":"99451_CR53","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2174\/15734099113096660036","volume":"9","author":"KD Dubey","year":"2013","unstructured":"Dubey, K. D. & Ojha, R. K. T. Recent advances in protein\u2212ligand interactions: Molecular dynamics simulations and binding free energy. Curr. Comput. Aided Drug Des. 9, 518\u2013531 (2013).","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"99451_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","volume":"9","author":"DS Goodsell","year":"1996","unstructured":"Goodsell, D. S., Morris, G. M. & Olson, A. J. Automated docking of flexible ligands: Applications of AutoDock. J. Mol. Recognit. 9, 1\u20135 (1996).","journal-title":"J. Mol. Recognit."},{"key":"99451_CR55","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/157489312803901063","volume":"7","author":"LS Azevedo","year":"2012","unstructured":"Azevedo, L. S. et al. Recent progress of molecular docking simulations applied to development of drugs. Curr. Bioinform. 7, 352\u2013365 (2012).","journal-title":"Curr. Bioinform."},{"key":"99451_CR56","first-page":"1","volume":"1","author":"CMR Sant\u2019Anna","year":"2009","unstructured":"Sant\u2019Anna, C. M. R. Molecular modeling methods in the study and design of bioactive compounds: An introduction. Rev. Virtual Qu\u00edmica 1, 1 (2009).","journal-title":"Rev. Virtual Qu\u00edmica"},{"key":"99451_CR57","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.drudis.2007.07.006","volume":"12","author":"K Raha","year":"2007","unstructured":"Raha, K. et al. The role of quantum mechanics in structure-based drug design. Drug Discov. Today 12, 725\u2013731 (2007).","journal-title":"Drug Discov. Today"},{"key":"99451_CR58","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/B978-0-12-398312-1.00011-1","volume":"87","author":"A Lodola","year":"2012","unstructured":"Lodola, A. & De Vivo, M. The increasing role of QM\/MM in drug discovery. Adv. Protein Chem. Struct. Biol. 87, 337\u2013362 (2012).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"99451_CR59","doi-asserted-by":"publisher","unstructured":"Browning, D. J. Pharmacology of Chloroquine and Hydroxychloroquine BT: Hydroxychloroquine and Chloroquine Retinopathy. in (ed. Browning, D. J.) 35\u201363 (Springer, 2014). doi:https:\/\/doi.org\/10.1007\/978-1-4939-0597-3_2.","DOI":"10.1007\/978-1-4939-0597-3_2"},{"key":"99451_CR60","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1038\/s41401-020-00537-9","volume":"42","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice. Acta Pharmacol. Sin. 42, 1195\u20131200 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"99451_CR61","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1021\/acsptsci.0c00076","volume":"3","author":"AJ Wiemer","year":"2020","unstructured":"Wiemer, A. J. Metabolic efficacy of phosphate prodrugs and the remdesivir paradigm. ACS Pharmacol. Transl. Sci. 3, 613\u2013626 (2020).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"99451_CR62","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-021-10215-5","author":"I Celik","year":"2021","unstructured":"Celik, I., Erol, M. & Duzgun, Z. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-021-10215-5 (2021).","journal-title":"Mol. Divers."},{"key":"99451_CR63","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1039\/b901179j","volume":"134","author":"M Brown","year":"2009","unstructured":"Brown, M. et al. Mass spectrometry tools and metabolite-specific databases for molecular identification in metabolomics. Analyst 134, 1322\u20131332 (2009).","journal-title":"Analyst"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99451-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99451-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T11:30:12Z","timestamp":1699615812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99451-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,7]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99451"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99451-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,7]]},"assertion":[{"value":"8 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19998"}}